Hosted on MSN1mon
BeiGene wins FDA nod for Tevimbra in gastric cancerThe approval comes ahead of the cancer-focused biotech's plans to change its name to BeOne Medicines and switch its Nasdaq ticker symbol to “ONC” on January 2, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback